2/16
02:12 am
maze
Maze Therapeutics Chief Medical Officer Sells 15K Shares As Company's Stock Continues to Surge [Yahoo! Finance]
Low
Report
Maze Therapeutics Chief Medical Officer Sells 15K Shares As Company's Stock Continues to Surge [Yahoo! Finance]
2/14
07:51 pm
maze
Maze Therapeutics (MAZE) Valuation Check After Strong 1 Year Shareholder Return [Yahoo! Finance]
Low
Report
Maze Therapeutics (MAZE) Valuation Check After Strong 1 Year Shareholder Return [Yahoo! Finance]
2/7
02:07 am
maze
Maze Therapeutics (NASDAQ:MAZE) was downgraded by analysts at
Wall Stree
Medium
Report
Maze Therapeutics (NASDAQ:MAZE) was downgraded by analysts at
Wall Stree
2/4
07:00 am
maze
Maze Therapeutics to Participate in the Guggenheim Emerging Outlook: Biotech Summit 2026
Low
Report
Maze Therapeutics to Participate in the Guggenheim Emerging Outlook: Biotech Summit 2026
2/1
07:03 pm
maze
Maze Therapeutics SVP Sells 5,000 Shares Amid Historic First Year for the Company's Stock [Yahoo! Finance]
Medium
Report
Maze Therapeutics SVP Sells 5,000 Shares Amid Historic First Year for the Company's Stock [Yahoo! Finance]
1/28
10:12 am
maze
Maze Therapeutics (NASDAQ:MAZE) had its "buy" rating reaffirmed by analysts at HC Wainwright.
Low
Report
Maze Therapeutics (NASDAQ:MAZE) had its "buy" rating reaffirmed by analysts at HC Wainwright.
1/25
03:05 am
maze
Maze Therapeutics (NASDAQ:MAZE) was upgraded by analysts at
Wall Street
Low
Report
Maze Therapeutics (NASDAQ:MAZE) was upgraded by analysts at
Wall Street
1/17
01:11 am
maze
Maze Therapeutics (NASDAQ:MAZE) was downgraded by analysts at
Wall Stree
Medium
Report
Maze Therapeutics (NASDAQ:MAZE) was downgraded by analysts at
Wall Stree
11/6/2025
04:01 pm
maze
maze therapeutics, inc.
BEAT
Report
-3.5%
maze therapeutics, inc.
8/12/2025
04:01 pm
maze
maze therapeutics, inc.
BEAT
Report
-1.0%
maze therapeutics, inc.
2/13
05:31 pm
maze
Form SCHEDULE 13G/A Maze Therapeutics, Inc. Filed by: Frazier Life Sciences Public Fund, L.P.
Low
Report
Form SCHEDULE 13G/A Maze Therapeutics, Inc. Filed by: Frazier Life Sciences Public Fund, L.P.
2/13
05:25 pm
maze
Form SCHEDULE 13G/A Maze Therapeutics, Inc. Filed by: Third Rock Ventures IV, L.P.
Low
Report
Form SCHEDULE 13G/A Maze Therapeutics, Inc. Filed by: Third Rock Ventures IV, L.P.
2/6
04:32 pm
maze
Form SCHEDULE 13G/A Maze Therapeutics, Inc. Filed by: GV 2019, L.P.
Medium
Report
Form SCHEDULE 13G/A Maze Therapeutics, Inc. Filed by: GV 2019, L.P.
2/4
05:21 pm
maze
Form S-8 Maze Therapeutics, Inc.
Medium
Report
Form S-8 Maze Therapeutics, Inc.
2/4
05:18 pm
maze
Form S-3ASR Maze Therapeutics, Inc.
Medium
Report
Form S-3ASR Maze Therapeutics, Inc.
2/4
04:46 pm
maze
Form 8-K Maze Therapeutics, Inc. For: Feb 02
Medium
Report
Form 8-K Maze Therapeutics, Inc. For: Feb 02
2/4
04:26 pm
maze
Form 4 Maze Therapeutics, Inc. For: Feb 02 Filed by: Bernstein Harold
Medium
Report
Form 4 Maze Therapeutics, Inc. For: Feb 02 Filed by: Bernstein Harold
2/4
04:23 pm
maze
Form 4 Maze Therapeutics, Inc. For: Feb 02 Filed by: Bachrodt Amy
Medium
Report
Form 4 Maze Therapeutics, Inc. For: Feb 02 Filed by: Bachrodt Amy
News Stats
All News
News Wires
Media Monitoring
SEC Edgar Filings
Upgrades
Downgrades
Initiated
Reiterated
Last Earnings
Last Earnings EPS
Next Earnings
Order Stats
Sub-Penny
Odd lot
Avg. bid-ask spread
Avg. bid-ask size
Shares at ask/bid
Off exchange
Main News & Impact Reports
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below:
Register